MedPath

Effect of strontium ranelate (2g per day) in the management of lower limb fractures with delayed-union or non union: an international open label study in patients with osteoporosis - ND

Conditions
Delayed and non-united fractures in osteoporotic patients
MedDRA version: 12.1Level: LLTClassification code 10031283Term: Osteoporosis fracture
Registration Number
EUCTR2009-017039-16-IT
Lead Sponsor
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

- Osteoporotic patients, - With a fracture of the lower limbs with delayed union, defined as an absence of radiological full union after 6 months according to investigator`s opinion OR with non-union defined as non-union for at least 6 months and no sign of radiological healing or bone reaction since at least 3 months, - Ambulatory prior to the qualifying fracture.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not pathological fracture, - Bone-related disease other than osteoporosis, - Septic or synovial or congenital pseudarthrosis, - Fracture with a fracture gap, after reduction or treatment, greater than more the half the width of the affected bone, - Concomitant treatments interfering with bone metabolism, - History of venous thrombo-embolism, - History of intolerance, allergy or hypersensitivity to strontium ranelate, - Contraindication to Calperos D3.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To assess the effects of strontium ranelate in the management of aseptic fractures of the lower limbs with delayed union or non-union.;Secondary Objective: ;Primary end point(s): Radiological state at the fractured site asessessed by radiography, - Time to progression, - Algofunctional behaviour of the affected limb, - Pain intensity using a Visual Analogue Scale of 10 cm, - Full recovery to walk and improvement to walk, - Secondary surgical interventions, - Quality of Life, - Improvement in mobility.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath